Category Archives: Science

Science Press Releases & News distributed via EuropaWire

Roche’s Kadcyla Demonstrates Long-Term Survival Benefit in HER2-Positive Early Breast Cancer

(IN BRIEF) Roche has released positive long-term follow-up data from the Phase III KATHERINE study, evaluating Kadcyla® (trastuzumab emtansine) as adjuvant therapy for people with HER2-positive early-stage breast cancer (eBC) who have residual invasive disease following neoadjuvant treatment. The study … Read the full press release

Roche Reports Positive Phase III Results for Inavolisib Combination Therapy in PIK3CA-Mutated Breast Cancer

(IN BRIEF) Roche has announced promising results from the Phase III INAVO120 study, which evaluated inavolisib in combination with palbociclib (Ibrance®) and fulvestrant as a first-line treatment for individuals with PIK3CA-mutated, hormone receptor (HR)-positive, HER2-negative, endocrine-resistant, locally advanced, or metastatic … Read the full press release

BioNTech Enters Multi-Year Strategic Partnership with Victoria, Australia, to Boost Local mRNA Ecosystem

(IN BRIEF) BioNTech, a leading biotechnology company, has formalized a multi-year strategic partnership with the State of Victoria in Australia, building upon a prior Letter of Intent established in October 2022. The collaboration aims to strengthen the local mRNA ecosystem … Read the full press release

Philips-Led Consortium Receives €6.5 Million Grant to Enhance Coronary Artery Disease Diagnosis and Treatment

(IN BRIEF) The COMBINE-CT consortium, led by Philips and supported by a €6.5 million grant from the Innovative Health Initiative (IHI), is dedicated to improving the diagnosis and treatment of coronary artery disease (CAD). CAD, characterized by the accumulation of … Read the full press release

University of Amsterdam Professors Appointed to NWO’s SSH Domain Board

(IN BRIEF) NWO’s Executive Board has announced the appointment of Prof. Dr. Guda van Noort and Dr. Nicky Pouw, both from the University of Amsterdam, to the Board of the Social Science and Humanities (SSH) Domain. Guda van Noort is … Read the full press release

Sanofi’s Robust Pipeline and Strategic Focus Aim to Lead Immunology Industry

(IN BRIEF) Sanofi is showcasing its ambitious pipeline transformation strategy, which includes a record 12 potential blockbuster opportunities currently under clinical evaluation. Among these, there are nine innovative medicines and vaccines with peak sales potential ranging from €2 to €5 … Read the full press release

Sarclisa Combination Treatment Shows Promise in Phase 3 Trial for Newly Diagnosed Multiple Myeloma Patients

(IN BRIEF) The Phase 3 IMROZ trial, assessing the use of Sarclisa® (isatuximab) in combination with standard-of-care bortezomib, lenalidomide, and dexamethasone (VRd), has achieved its primary efficacy endpoint at a planned interim analysis. The trial demonstrated a statistically significant improvement … Read the full press release

BASF Commits to Scope 3.1 Emission Reductions, Targets Net Zero by 2050

(IN BRIEF) BASF, a major player in the chemical industry, has announced new sustainability commitments, including targets for Scope 3.1 emissions. The company aims to reduce its specific Scope 3.1 emissions by 15% by 2030 compared to 2022 levels. This … Read the full press release

BASF and Heidelberg University Commit to Advancing Sustainable Chemistry with Catalysis Research Lab (CaRLa) Extension

(IN BRIEF) BASF and Heidelberg University have extended their partnership for another five years to continue operating the Catalysis Research Laboratory (CaRLa) until 2028. CaRLa, founded in 2006, focuses on homogeneous catalysis and organic synthesis, with the aim of developing … Read the full press release

Navigating 2024: BNP Paribas Identifies Key Investment Trends

(IN BRIEF) BNP Paribas Wealth Management has outlined key investment themes for 2024. These include seeking real returns through inflation-protected income, investing in sectors benefiting from the shift away from globalization, capitalizing on energy transition and electrification, diversifying portfolios beyond … Read the full press release

University of Exeter to Lead €9.75 Million Research Project Addressing Inequality and Discrimination in Europe

(IN BRIEF) Professor Susan Banducci from the University of Exeter will lead the Infra4NextGen research project, funded by the European Commission with €9.75 million over four years, to address inequality, racism, and xenophobia in Europe. The research aims to support … Read the full press release

CERN’s Successful Niobium–Tin Magnet Test Opens New Possibilities for High-Luminosity LHC Upgrade

(IN BRIEF) Engineers at CERN have successfully tested an improved design of a quadrupole magnet using niobium–tin (Nb3Sn) technology. These magnets are crucial for controlling particle beams in the Large Hadron Collider (LHC). The tests confirm that the newly designed … Read the full press release

UK Becomes Associated Country to Horizon Europe, Gains Access to Research and Innovation Funding

(IN BRIEF) Starting from January 1, 2024, the United Kingdom will officially become an associated country to Horizon Europe, the European Union’s research and innovation program. This milestone was achieved as the EU-UK Specialized Committee on Participation in Union Programs … Read the full press release

Surprising Discovery: Excited Electrons Straighten Perovskite Nanocrystals

(IN BRIEF) Researchers from ETH Zurich, Empa, and Stanford University have made a remarkable discovery that excited electrons can straighten the crystal lattice of perovskite nanocrystals, increasing their symmetry rather than causing disorder. This unexpected finding could pave the way … Read the full press release

Roche to Acquire Carmot Therapeutics for USD 2.7 Billion, Expanding Its Portfolio in Obesity Treatment

(IN BRIEF) Roche, a leading pharmaceutical company, has announced its definitive merger agreement to acquire Carmot Therapeutics, a privately owned US-based company specializing in obesity treatment and related metabolic diseases. The acquisition includes Carmot’s portfolio of clinical stage subcutaneous and … Read the full press release

Airbus Begins Production of Galileo Second Generation Satellites in Germany

(IN BRIEF) Airbus has commenced full-scale production of the Galileo Second Generation (G2) satellites at its facility in Friedrichshafen, Germany. The first satellite flight model structure has arrived from Beyond Gravity in Zurich and will undergo final integration and testing … Read the full press release

Leading Institutions Join VINCI in Fourth Cycle of Environmental Research

(IN BRIEF) VINCI, in partnership with AgroParisTech, Mines Paris-PSL, and École des Ponts ParisTech, has renewed its commitment to environmental research with a budget of €6 million until 2028. The collaboration aims to address key environmental challenges, including energy efficiency … Read the full press release

Skanska Secures $106M Contract to Construct North Carolina State University’s State-of-the-Art Integrative Sciences Building

(IN BRIEF) Skanska, a leading construction company, has announced a new contract agreement with North Carolina State University for the construction of a cutting-edge integrative sciences building in Raleigh, North Carolina, USA. This project, valued at USD 106 million (approximately … Read the full press release

Sanofi’s CHC Launches Shared Care Collective with Global Experts to Advance Health and Sustainability Initiatives

(IN BRIEF) Sanofi’s Consumer Healthcare business unit (CHC) has introduced the Shared Care Collective, an advisory board consisting of experts from various fields, both internal and external, to bolster sustainability efforts within the CHC business. This initiative aims to foster … Read the full press release

University of Liverpool Researcher Secures Wellcome Trust Career Development Award to Investigate Coronavirus Replication Mechanisms

(IN BRIEF) Dr. Edward Emmott, a researcher at the University of Liverpool, has received the prestigious Wellcome Trust Career Development Award, a highly competitive fellowship. This funding will support Dr. Emmott’s crucial research efforts aimed at gaining a deeper understanding … Read the full press release

Eppendorf’s BioBased Lab Consumables Offer Sustainable Alternatives Powered by Neste

(IN BRIEF) Eppendorf, a laboratory equipment manufacturer, has partnered with Neste, a renewable solutions company, to create Eppendorf Consumables BioBased, a line of lab consumables made from 100% renewable raw materials. These products, including tubes and pipette tips, offer a … Read the full press release

Nierstichting and NWO Partner to Advance Kidney Transplant Survival

(IN BRIEF) Despite technological advancements, the long-term survival of transplanted kidneys has seen little improvement in the past two decades, with approximately 40% of transplanted kidneys being rejected within ten years. In response, the Nierstichting and NWO are collaborating in … Read the full press release

Marcel Levi Re-elected Vice-President on the Renewed Board of Science Europe

(IN BRIEF) Marcel Levi, NWO board chair, has been re-elected as vice-president on the newly constituted board of Science Europe, a European partnership of research funders and performers. His two-year term will extend until November 2025. Levi was previously a … Read the full press release

AstraZeneca Showcases Hematology Advancements and Calquence’s Long-Term Efficacy at ASH Annual Meeting

(IN BRIEF) AstraZeneca is set to unveil promising data at the 65th American Society of Hematology (ASH) Annual Meeting, highlighting its expanding hematology pipeline and the enduring effectiveness of Calquence in treating chronic lymphocytic leukemia (CLL). The presentation includes six-year … Read the full press release

Novartis Outlines ‘Pure Play’ Innovative Medicines Strategy and Focused R&D Pipeline at London Event

(IN BRIEF) Novartis, a leading pharmaceutical company, presented its ‘pure play’ innovative medicines strategy and focused Research and Development (R&D) pipeline at an event in London. The company’s CEO, Vas Narasimhan, emphasized Novartis’ transformation into an innovative medicines-focused firm, highlighting … Read the full press release

Boehringer Ingelheim Leverages IBM’s AI Tech for Novel Antibody Development

(IN BRIEF) Boehringer Ingelheim and IBM have formed a partnership to expedite the discovery of novel candidate antibodies for therapeutic purposes. Boehringer will utilize IBM’s foundation model technologies, combining them with their proprietary data to enhance the antibody discovery process. … Read the full press release

University of Exeter Research Teams Triumph at GW4 Open Research Prize

(IN BRIEF) University of Exeter researchers received accolades at the inaugural GW4 Open Research Prize, an event celebrating excellence in open research practices. Open research encompasses various practices that enhance research accessibility, transparency, reproducibility, and visibility. Exeter researchers claimed first … Read the full press release

EU-Funded REFORMERS Project Launches Europe’s First Renewable Energy Valley in the Netherlands

(IN BRIEF) The REFORMERS research project, funded under the EU’s Horizon Europe program, has officially commenced its mission to develop and roll out “Renewable Energy Valleys” (REVs) across Europe. The project’s flagship, located in the Netherlands between Alkmaar and Heiloo, … Read the full press release

Roche Introduces Elecsys® HBeAg Quant Test for Accurate Hepatitis B Diagnosis and Monitoring

(IN BRIEF) Roche has unveiled Elecsys® HBeAg quant, a new immunoassay designed to detect the presence and quantity of the hepatitis B e antigen (HBeAg) in human serum and plasma. This diagnostic tool simplifies the process for both clinicians and … Read the full press release

GSK’s Belantamab Mafodotin Shows Promise as Second-Line Treatment for Multiple Myeloma in Phase III Trial

(IN BRIEF) GlaxoSmithKline (GSK) has reported positive results from the interim efficacy analysis of the DREAMM-7 phase III trial evaluating belantamab mafodotin as a second-line treatment for relapsed or refractory multiple myeloma. The trial successfully met its primary endpoint of … Read the full press release

Dupixent Shows Remarkable Efficacy in Reducing COPD Exacerbations in Second Phase 3 Trial

(IN BRIEF) In a significant development, the second investigational Phase 3 trial of Dupixent® (dupilumab) for chronic obstructive pulmonary disease (COPD), known as NOTUS, has demonstrated promising results. The trial found that Dupixent reduced COPD exacerbations by 34% compared to … Read the full press release

New Research Challenges Perception of Ultra-Processed Foods’ Palatability, Highlights Human Food Preferences

(IN BRIEF) A recent study led by the University of Bristol’s Nutrition and Behaviour Group has questioned the assumption that ultra-processed foods (UPFs) are inherently more appealing than less processed alternatives. The research, involving 224 adult volunteers, compared taste perceptions … Read the full press release

Philips Unveils Mobile MRI System with Helium-Free Operations for Enhanced Patient-Centric Care at #RSNA23

(IN BRIEF) Royal Philips has introduced the world’s first mobile MRI system with helium-free operations, known as BlueSeal MR Mobile, at #RSNA23, the prominent medical imaging conference. This groundbreaking technology offers flexible and agile MRI services, allowing placement in more … Read the full press release

Philips Unveils Cutting-Edge Healthcare Innovations at #RSNA23 Focused on Enhancing Patient Care and Efficiency

(IN BRIEF) Royal Philips, a global leader in health technology, has showcased its commitment to improving patient care and healthcare providers’ efficiency at #RSNA23, the world’s largest medical imaging conference. Recognizing the challenges faced by radiologists and healthcare staff, with … Read the full press release

Unique Fusion of Science and Music Sells Out Arlington Baths Club in Glasgow

(IN BRIEF) The “Swimming with Gravitational Waves” event, held at Glasgow’s Arlington Baths Club, achieved a sold-out success as all 180 tickets for the unique fusion of science and music were purchased in advance. Organized in collaboration with physicists from … Read the full press release

Beyond EPICA Project’s Third Ice Core Drilling Season Begins in Antarctica

(IN BRIEF) The Beyond EPICA 23/24 team has initiated the third drilling season at Little Dome C in Antarctica, located near the Concordia Station. This international research project, led by the Institute of Polar Sciences of the National Research Council … Read the full press release

Schneider Electric to Advocate for Rapid and Equitable Net-Zero Transition at COP28

(IN BRIEF) Schneider Electric, a leader in energy management and automation, is participating in the COP28 United Nations Climate Change Conference in Dubai. The company’s CEO and Chairman will attend the conference to advocate for an accelerated and equitable transition … Read the full press release

Chinese Medical Device Manufacturer Ezisurg Receives MDR Certification for Powered Endoscopic Stapler from TÜV Rheinland

(IN BRIEF) TÜV Rheinland, an international third-party testing, inspection, and certification services provider, has awarded Ezisurg Medical Co., Ltd. its first MDR (Medical Device Regulation) certificate of conformity in Greater China for its “Disposable Powered Endoscopic Stapler and Cartridge.” This … Read the full press release

Study Links Higher Consumption of Ultra-Processed Foods to Elevated Risk of Upper Aerodigestive Tract Cancers

(IN BRIEF) A study led by researchers from the University of Bristol and the International Agency for Research on Cancer (IARC) has found an association between increased consumption of ultra-processed foods (UPFs) and a higher risk of developing cancers of … Read the full press release

Merck Expands Biologics Testing Center in China to Support Local Biopharma Innovation

(IN BRIEF) Merck has completed the second phase of its new €29 million Biologics Testing Center in China, adding 1,500 square meters to the facility. This expansion includes the first biosafety laboratories for Merck in the Chinese market, enabling clients … Read the full press release